Sources and media credits
The evidence and creative work behind the experience. Find the source, reporting context and creator for the data, research, photography and films used across NEUVIOR.
Homepage film
Scientific cinema.
An original NEUVIOR editorial sequence, bringing laboratory work, a public molecular structure and medicines manufacturing into one silent film.
The 24-second homepage background combines three licensed stock passages with an original three-dimensional camera study. The full captured molecular frame is contained in the film master; the page frames that master responsively. The film plays once, pauses outside the viewport and offers a small replay control. Reduced-motion visitors receive a still frame.
- 0–4 seconds | A liquid drop
- Pipette Dispenses Drop of Liquid Under Blue Light, BlackBoxGuild, Envato item FF9FY2D. Extracted from the held licensed master; a cool editorial grade was applied.
- 4–8 seconds | At the microscope
- Cells Sample Placed on Microscope Platform, BlackBoxGuild, Envato item 9FZQSWS. Licensed contextual footage of sample placement.
- 8–18 seconds | Molecular structure
- Original camera and ribbon geometry derived from PDB 4HHB, human deoxyhaemoglobin, an experimental X-ray structure reported at 1.74 Å. It uses 574 deposited alpha-carbon positions, carbonyl directions, helix annotations and recorded haem coordinates. Camera playback is edited to fit the ten-second passage; molecular conformation remains fixed.
- 18–24 seconds | Medicines making
- Automatic Machine Production of Medicine Capsules in Factory, inmicco, Envato item 84R3UX4. Forward machinery footage from the held licensed master, with a restrained editorial grade.
The stock passages were licensed through the existing Envato subscription on 13 October 2026. Original molecular visuals were created with Three.js 0.186.1, available under the MIT licence. PDB archive coordinates are available under CC0 1.0.
Fermi, G., Perutz, M.F., Shaanan, B. and Fourme, R. (1984) ‘The crystal structure of human deoxyhaemoglobin at 1.74 Å resolution’, Journal of Molecular Biology, 175, pp. 159–174. Original publication. PDB 4HHB, coordinates via RCSB PDB.
These are contextual and illustrative visuals. The stock footage does not show a NEUVIOR laboratory or manufacturing facility. The molecular passage depicts no binding event, therapeutic response, PHARMORIS mechanism or NEUVIOR research result. Ribbon widths, colours and metallic finishes are editorial; the deposited entry’s structural caveats remain part of its source record.
Medicines in blue
Pills in Blister Pack on a Dark Background | BeyondThis | Envato stock photography.
A blue-lit photograph of silver medicine blister packaging, selected for the Medicines Intelligence field. This is contextual stock photography; it does not identify a medicine manufactured or supplied by NEUVIOR.
Source: https://app.envato.com/search/photos/92e6b586-de61-44d8-ac2d-f8d94de77587
Licensed through the existing Envato subscription on 13 October 2026.
Chrome waves
Shimmering Liquid Metal Waves Abstract Motion Background | pixel-dna | Envato item JY9WVCS.
A rendered motion graphic, with still frames extracted from the licensed film for visual treatments. The blue and silver imagery is an abstract design element, not a recording of a NEUVIOR material or a scientific result.
Source: https://elements.envato.com/chrome-fabric-JY9WVCS
Licensed through the existing Envato subscription on 13 October 2026.
Research at the microscope
Cells Sample Placed on Microscope Platform | BlackBoxGuild | Envato item 9FZQSWS.
Filmed stock footage showing a gloved hand placing a multiwell sample plate on a microscope platform. The website still is a frame extracted from the licensed film.
The footage provides research context. It does not depict a NEUVIOR experiment, establish the identity of the sample or demonstrate results from a NEUVIOR programme.
Source: https://elements.envato.com/petri-dish-under-microscope-in-research-lab-9FZQSWS
Licensed through the existing Envato subscription on 13 October 2026.
Capsule manufacturing
Automatic Machine Production of Medicine Capsules in Factory | inmicco | Envato item 84R3UX4.
Filmed stock footage of capsules moving through manufacturing machinery. The website still is a frame extracted from the licensed film, selected to give the Resource Economics field a concrete industrial context.
The machinery and facility are not presented as owned or operated by NEUVIOR. The footage does not demonstrate a NEUVIOR production process or a resource-efficiency result.
Source: https://elements.envato.com/automatic-capsule-filling-machine-84R3UX4
Licensed through the existing Envato subscription on 13 October 2026.
NCI microscope photography
National Cancer Institute | Unsplash License.
Research photography selected for editorial context. The image does not depict a NEUVIOR facility, team member or experiment.
Original photograph: https://unsplash.com/photos/silhouette-of-person-using-microscope-ct10qdGv1hQ
Licence: https://unsplash.com/license
NCI laboratory photography
National Cancer Institute | Unsplash License.
Research photography selected for editorial context. The image does not depict a NEUVIOR facility, team member or experiment.
Original photograph: https://unsplash.com/photos/woman-dropping-a-specimen-on-a-test-tube-DYQfoftWGXw
Licence: https://unsplash.com/license
Community pharmacy photography
David Trinks | Unsplash License.
Editorial context | a third party pharmacy, not a PHARMORIS deployment
Original photograph: https://unsplash.com/photos/a-pharmacy-shelf-filled-with-lots-of-medicine-bottles-mLaIFEtUZFs
Licence: https://unsplash.com/license
Industrial process photography
Barnaby | Unsplash License.
Editorial context | industrial resource and energy challenges, not a NEUVIOR facility
Original photograph: https://unsplash.com/photos/industrial-refinery-with-smoking-stacks-under-a-cloudy-sky-0w3nOe1j29I
Licence: https://unsplash.com/license
Research in focus
A 12-second silent photographic motion study produced for NEUVIOR from National Cancer Institute photography on Unsplash. The movement is an editorial treatment of a still photograph, not a recording of an experiment conducted by NEUVIOR.
The film contains no spoken information. The original microscope photograph is credited above under NCI microscope photography.
Original photograph: https://unsplash.com/photos/silhouette-of-person-using-microscope-ct10qdGv1hQ
Licence: https://unsplash.com/license
Optical light
Dynamic Lens Flare Light Leak Overlay | SvenHastedt | Envato item DRHWZXY.
Filmed optical light selected as an abstract atmosphere for editorial chapters. Colour and movement support the page design; they do not represent a physiological signal, a scientific measurement or PHARMORIS output.
Licensed through the existing Envato subscription on 13 October 2026. Silent, compressed derivatives and poster frames were prepared from the licensed source.
The scale of medicines
NHS Business Services Authority | Prescription Cost Analysis England 2025/26 | Published 4 June 2026. The interactive chapter uses the current official additional tables, Table A1, for the ten financial years 2016/17 to 2025/26.
The 2025/26 observations are 1,297,516,707 prescription items and £11,641,873,550.60 net ingredient cost. Values in the display are rounded for readability; the source table retains the exact observations. Prescription items are not individual people or the number of prescription forms.
Net ingredient cost is based on the basic price of the medicine or appliance, before dispenser discounts and excluding dispensing fees. It is not the pharmacy’s purchase cost or total net NHS expenditure. Costs reflect changes in quantities, mix and prices.
Coverage changes in 2025/26 include new seasonal influenza vaccination reporting. The chart retains that reporting-change note so annual change is not read as a strictly like-for-like demand measure.
Contains public sector information licensed under the Open Government Licence v3.0. Source data and definitions remain the authority for scope and interpretation.
Medicines spending and the pharmacy estate
NHSBSA’s estimated £21.4 billion NHS commissioner cost for England covers calendar 2025, after central rebates, and includes medicines, appliances, dressings and devices. It uses a different period and cost basis from the Prescription Cost Analysis chart. The two figures must not be added or treated as PHARMORIS revenue or savings.
The 10,407 community-pharmacy figure is the number open at 31 March 2025 in England, rather than every pharmacy submitting during the year. The source release covers 2015/16 to 2024/25.
CMS reports US retail prescription-drug expenditure of $467.0 billion in calendar 2024. This retail category does not include every medicine used in hospitals and is not a PHARMORIS market-size calculation.
PHARMORIS evidence and assurance
The evidence agenda describes development questions and planned evaluations. It does not report clinical validation, regulatory approval, NHS deployment or achieved customer outcomes.
The public UKRI record identifies NEUVIOR’s £49,928 PHARMORIS development award, project 10173524. The award record supports the funding statement; it is not a product certification or procurement endorsement.
NHS Digital Technology Assessment Criteria, NICE’s evidence standards framework and MHRA intended-purpose guidance inform the assessment work appropriate to a defined technology and setting. Referencing these frameworks does not claim PHARMORIS has passed an assessment.
Resource research and sustainability
NHS England’s 2024/25 footprint account assigns 17% of NHS Carbon Footprint Plus to medicines and prescribing. Direct emissions from inhalers and anaesthetic gases are treated separately. This contextual share is not a measured NEUVIOR reduction.
The ACS Pharmaceutical Roundtable’s process mass intensity metric relates the total mass of material inputs to the mass of product. Any interactive example is an openly stated scenario, rather than a measurement from NEUVIOR or an environmental life-cycle assessment.
Evergreen Level 3 is a target and B Corp certification is a planned journey. They are not current awarded credentials.
Constellation and the Vertex concept
The V-shaped campus is an original spatial concept prepared for design review. It is not a photograph of an operating campus, a planning application or a final architectural design. Its purpose is to examine the research wing, enterprise wing, public apex, garden and servicing arrangement before detailed production.
The 14 October 2026 Vertex refinement and 26-second flyover are rendered from original editable geometry: two working wings, a public gallery, an open central passage and a common garden. The finite camera journey has separate desktop and portrait compositions. These are architectural design studies; dimensions, uses and landscape elements are concepts for development, rather than certified engineering or a built facility.
Poly Haven (n.d.), Qwantani Dusk 1 (Pure Sky). Sky photography by Greg Zaal; processing by Jarod Guest. The unchanged 1K photographic HDR supplies environmental lighting and a sky background for the original Vertex scene. Photographic sky source | CC0 licence. It depicts sky, rather than a proposed location or NEUVIOR site. The campus film and stills are actual renders of the concept geometry.
The eight-destination ambition is a long-term development aim for 2045. Each phase requires a viable local case, suitable capability, occupiers, partners and finance. It is not a committed construction programme.
Scottish Enterprise’s H1 2026 life-sciences property review provides demand context: 35 of 70 active accommodation enquiries sought 2,500 square feet or less. The enquiries and supply figures are market observations, not NEUVIOR reservations, a list of customers or evidence of demand for a specific site.
The AMIDS visit photograph records Founder Varun Sharma’s personal site visit on 1 August 2026. Its historical article retains the source and observations. Other licensed campus or architecture material is identified separately and must not be mistaken for AMIDS or a commissioned NEUVIOR building.
Publication marks and public support
Publisher marks identify linked coverage, founder commentary or appearances. Their presence does not imply that a publisher endorses NEUVIOR or PHARMORIS. Each newsroom record identifies its source and distinguishes editorial coverage, contributions and syndicated appearances.
White and silver publisher treatments are visual adaptations for the dark website. The full-colour marks are retained where appropriate in the newsroom. Publisher names and marks remain the property of their respective owners.
Public funding and support marks accompany the specific supported work. The corresponding award record determines the project, recipient and scope.
Materials in close view
Pipette Dispenses Drop of Liquid Under Blue Light | BlackBoxGuild | Envato item FF9FY2D.
A real filmed close-up of a blue-lit pipette tip and drop. The website extract uses 00:30–00:42 of the licensed source. It provides materials-testing context; the sample identity, measurement and outcome are not established, and the footage does not depict a NEUVIOR or ZYLON experiment.
Licensed through the existing Envato subscription on 13 October 2026. The silent extract is not a seamless loop.
Three.js and the interactive Vertex study
The interactive Vertex study uses Three.js, distributed under the MIT licence. The original site-independent geometry, controls and spatial design were prepared for NEUVIOR. No external building model or generated image is used in this study.
Glass fluid
Abstract Blue Glassy Fluid Background Loop | vinkfan | Envato item 8NYNELG.
Rendered abstract glass imagery, selected for editorial motion and the PHARMORIS reading experience. It does not depict a medicine, biological structure, clinical signal or PHARMORIS interface.
Licensed through the existing Envato subscription on 13 October 2026. The complete clip is preserved in a silent web derivative. The supplier’s title and looping attributes conflict, so the website treats the footage as finite and offers an explicit replay.
International outlook
The globe is an editorial view of NEUVIOR’s international outlook. Its nine persistent highlighted places are not an office directory, a travel route or a list of confirmed projects. London represents the United Kingdom view, with Glasgow separately marked; Connecticut uses a geographic point within the state.
The globe uses Three.js under the MIT licence. Its land mask was prepared from the COBE project’s map texture. COBE code uses the MIT licence; the underlying world-map artwork carries separate Creative Commons Attribution-ShareAlike terms, retained in the attribution record.
Medicines category lens
NHSBSA | Prescription Cost Analysis England 2025/26 | Summary data tables, BNF_Chapters. The explorer preserves all 21 published chapter rows and their exact prescription-item and net ingredient cost values.
The all-PCA scope totals 1,297,516,707 items and £11,641,873,550.60 NIC. The medicinal-chapter scope, 01–15, totals 1,239,249,027 items and £9,983,762,289.24 NIC. Pseudo chapters 18–23 remain visibly separate; these include non-medicine supplies. Search limits the displayed rows while the selected scope remains the denominator.
BNF chapters are categories, not individual therapies or diagnoses. Average NIC per item depends on the mix of products and quantities. It is not a medicine price, patient cost or comparison of clinical value. The same PCA coverage and NIC definitions described above apply.
Contains public sector information licensed under the Open Government Licence v3.0. The local explorer and CSV export use the verified source snapshot; they are not a live PHARMORIS interface or a continuously refreshed data service.
Banu 2024 cell states
Banu et al. (2024), A cell state-specific metabolic vulnerability to GPX4-dependent ferroptosis in glioblastoma, The EMBO Journal 43, 4492–4521. Figure 1F. DOI 10.1038/s44318-024-00176-4. © The Author(s). Reused under Creative Commons Attribution 4.0: https://creativecommons.org/licenses/by/4.0/
The displayed image is a complete-panel crop from the publisher-served Figure 1. Original scientific colours, condition and channel labels, arrows, arrowheads and 10 µm scale bars are retained without retouching or recolouring. The source is external published murine-glioma research. It is not human GBM tissue, a NEUVIOR experiment or evidence of a clinical treatment.
Original article and complete figure: https://link.springer.com/article/10.1038/s44318-024-00176-4/figures/1
Discharge medicines pathways
NHS England’s NHS Discharge Medicines Service page provides the service context for the community-pharmacy chapter. Checked 13 October 2026. NEUVIOR’s DMS Commissioner Value Scan is a proposed company programme; the service reference identifies the existing NHS pathway, rather than an NHS commission or endorsement.
NHS England | NHS Discharge Medicines Service: https://www.england.nhs.uk/primary-care/pharmacy/pharmacy-services/nhs-discharge-medicines-service/
Public data and analysis sources
The NEUVIOR Data Analysis catalogue records publisher cadence, acquired snapshots, methods, scope and reuse. A catalogue entry is distinct from an acquired dataset or an active refresh service.
NHS Business Services Authority (2026) Prescription Cost Analysis. Available at: https://www.nhsbsa.nhs.uk/statistical-collections/prescription-cost-analysis-england/prescription-cost-analysis-england-202526 (Accessed: 13 October 2026).
NHS Business Services Authority (n.d.) English Prescribing Dataset with SNOMED Code. Available at: https://opendata.nhsbsa.net/dataset/english-prescribing-dataset-epd-with-snomed-code (Accessed: 13 October 2026).
Medicines and Healthcare products Regulatory Agency (n.d.) Medicines and device safety communications. Available at: https://www.gov.uk/drug-device-alerts (Accessed: 13 October 2026).
NHS Business Services Authority and NHS England (n.d.) Dictionary of medicines and devices. Available at: https://www.nhsbsa.nhs.uk/pharmacies-gp-practices-and-appliance-contractors/nhs-dictionary-medicines-and-devices-dmd (Accessed: 13 October 2026).
NHS England and SNOMED International (n.d.) SNOMED CT UK edition and Drug Extension. Available at: https://digital.nhs.uk/services/terminology-and-classifications/snomed-ct (Accessed: 13 October 2026).
NHS Business Services Authority (n.d.) BNF and SNOMED mapping. Available at: https://www.nhsbsa.nhs.uk/prescription-data/understanding-our-data/bnf-snomed-mapping (Accessed: 13 October 2026).
NHS Business Services Authority (n.d.) Discharge Medicines Service claims. Available at: https://www.nhsbsa.nhs.uk/prescription-data/dispensing-data/nhs-discharge-medicines-service (Accessed: 13 October 2026).
NHS Business Services Authority (n.d.) New Medicine Service claims. Available at: https://www.nhsbsa.nhs.uk/prescription-data/dispensing-data/complete-new-medicine-service-data (Accessed: 13 October 2026).
NHS Business Services Authority (n.d.) Drug Tariff. Available at: https://www.nhsbsa.nhs.uk/pharmacies-gp-practices-and-appliance-contractors/drug-tariff (Accessed: 13 October 2026).
Department for Energy Security and Net Zero (2026) Greenhouse-gas conversion factors 2026. Available at: https://www.gov.uk/government/publications/greenhouse-gas-reporting-conversion-factors-2026 (Accessed: 14 October 2026).
American Chemical Society | Green Chemistry Institute (2014) Process Mass Intensity method. Available at: https://www.acs.org/green-chemistry-sustainability/green-chemistry-nexus/articles/process-mass-intensity-calculation-tool.html (Accessed: 14 October 2026).
European Medicines Agency (2026) Chemistry of active substances guideline. Available at: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-chemistry-active-substances_en.pdf (Accessed: 14 October 2026).
Open Targets (n.d.) Open Targets Platform. Available at: https://platform.opentargets.org/ (Accessed: 13 October 2026).
US National Library of Medicine (n.d.) ClinicalTrials.gov public study records. Available at: https://clinicaltrials.gov/data-api/about-api (Accessed: 14 October 2026).
Public research poster and source figure
The GLIO poster brings published scientific context and NEUVIOR research design into a public proposal. The unchanged complete Banu et al. (2024), Figure 1F panel is attributed under CC BY 4.0, with channels, labels and scale bars retained. The PDF includes a full source companion. Read the research framework.
Interactive graphics and 3D software
Three.js (2026), version 0.186.1, MIT licence. https://github.com/mrdoob/three.js/blob/r186/LICENSE
Interactive data views are NEUVIOR source-derived analyses with methods shown alongside their figures. Constructed decision examples are identified as examples. Contextual stock films do not depict PHARMORIS output or NEUVIOR facilities.
PHARMORIS mechanical core
FilipZelinka (2025), Sci Fi Energy Core 1. Original artist model published through Sketchfab under Creative Commons Attribution 4.0. Artist and original model | CC BY 4.0 licence. Acquired through the offered signed-in downloads on 14 October 2026.
The PHARMORIS reading experience uses a declared NEUVIOR blue/cyan palette adaptation of the offered 1K GLB. Warm colour in the base-colour and emission atlases was changed; neutral metal detail, geometry, UVs, normal map, roughness/metalness map and hierarchy are retained. The unchanged original files are preserved separately.
The scroll-opening version is a further declared NEUVIOR adaptation. Nine actual mechanical assemblies were separated into named nodes while preserving every source triangle, its position, normal, tangent and UV data, along with all four blue-palette textures. The central housing and 52 surface details remain fixed; the actual annular rings and arc segments move from saved positions as the reader progresses through the four medicines questions. The opening sequence and viewpoint motion were authored for this website. They are not animation supplied by the artist.
The form is an editorial visual metaphor for connected medicines work. It can be turned and inspected from different viewpoints. It does not represent PHARMORIS software architecture, hardware, a medical device or validated clinical functionality. Credit identifies the artist and source; it does not imply their endorsement of NEUVIOR.
Molecular structure visualisation
The molecular film is an original NEUVIOR visualisation based on the published coordinates of human deoxyhaemoglobin, PDB 4HHB. The deposited X-ray structure is reported at 1.74 Å resolution (Fermi et al., 1984). RCSB PDB | 4HHB structure record.
Fermi, G., Perutz, M.F., Shaanan, B. and Fourme, R. (1984) The crystal structure of human deoxyhaemoglobin at 1.74 Å resolution. Journal of Molecular Biology, 175, pp.159–174. Original publication90472-8). PDB entry citation.
The coordinate archive is available under CC0. The original ribbon and haem geometry, camera and lighting composition uses Three.js (MIT). The molecular conformation remains fixed; the film is a reference-protein illustration, not a folding or molecular dynamics simulation, a glioblastoma mechanism or an original NEUVIOR experimental result. RCSB PDB | Citation and usage policy.
Vertex in daylight and after dark
The daylight and illuminated-night Vertex images are proposed architectural visualisations based on NEUVIOR’s original editable V-campus concept. Materials, planting, interiors and lighting are creative interpretations. Daylight and night are separate views of the proposed direction.
These concepts explore the two working wings, a shared public garden and the entrance threshold. The separate interactive flyover follows the original editable model. Explore the daylight and night concepts.
